{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:08:29Z","timestamp":1780628909341,"version":"3.54.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.clml.2014.12.004","type":"journal-article","created":{"date-parts":[[2014,12,12]],"date-time":"2014-12-12T03:50:13Z","timestamp":1418356213000},"page":"262-269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical Significance of Acquired Cytogenetic Clones in Patients With Treated Follicular Lymphoma"],"prefix":"10.1016","volume":"15","author":[{"given":"Xiaohong I.","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Cameron","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzaffar H.","family":"Qazilbash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2014.12.004_bib1","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1182\/blood-2006-10-041863","article-title":"How I treat indolent lymphoma","volume":"109","author":"Gribben","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.clml.2014.12.004_bib2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/sonc.2002.32749","article-title":"Rituximab in combination with CHOP improves survival in elderly\u00a0patients with aggressive non-Hodgkin's lymphoma","volume":"29","author":"Coiffier","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1016\/j.clml.2014.12.004_bib3","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1182\/blood-2006-03-013193","volume":"108","author":"Sebban","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.clml.2014.12.004_bib4","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1182\/blood-2003-02-0622","article-title":"High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable cohort analysis","volume":"102","author":"Gopal","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.clml.2014.12.004_bib5","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1182\/blood-2007-10-116749","volume":"111","author":"Ladetto","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clml.2014.12.004_bib6","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1046\/j.1365-2141.2000.01868.x","article-title":"Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes","volume":"108","author":"Sole","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2014.12.004_bib7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0268-960X(93)90019-Z","article-title":"Karyotypic analysis in primary myelodysplastic syndromes","volume":"7","author":"Noel","year":"1993","journal-title":"Blood Rev"},{"key":"10.1016\/j.clml.2014.12.004_bib8","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1200\/JCO.2003.07.113","article-title":"Treatment-related myelodysplasia and acute leukemia in non-Hodgkin's lymphoma patients","volume":"21","author":"Armitage","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2014.12.004_bib9","series-title":"World Health Organization Classification of Tumours Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"127","article-title":"Therapy-related myeloid neoplasms","author":"Vardiman","year":"2008"},{"key":"10.1016\/j.clml.2014.12.004_bib10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0145-2126(02)00161-3","article-title":"Clonal\u00a0cytogenetic abnormalities in bone marrow specimens without clear morphologic evidence of dysplasia: a form fruste of myelodysplasia?","volume":"27","author":"Steensma","year":"2003","journal-title":"Leuk Res"},{"key":"10.1016\/j.clml.2014.12.004_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1532\/LH96.06047","article-title":"Karyotypic identification of abnormal clones preceding morphological changes or occurring with no definite morphological features of myelodysplastic syndrome: a preliminary study","volume":"13","author":"Han","year":"2007","journal-title":"Lab Hematol"},{"key":"10.1016\/j.clml.2014.12.004_bib12","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1182\/blood-2013-07-512657","article-title":"Therapy-related acute myeloid\u00a0leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group","volume":"123","author":"Eichenauer","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.clml.2014.12.004_bib13","unstructured":"Lu G, CY, Abruzzo LV, et\u00a0al. Acquired silent cytogenetic clones arising in patients\u00a0treated successfully for lymphoma. USCAP Meeting\u00a02013. Baltimore, Maryland, USA."},{"key":"10.1016\/j.clml.2014.12.004_bib14","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/modpathol.2013.149","article-title":"B\u00a0acute lymphoblastic leukemia with t(14;19)(q32;p13.1) involving IGH\/EPOR: a clinically aggressive subset of disease","volume":"27","author":"Jaso","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.clml.2014.12.004_bib15","series-title":"ISCN: An International System for Human Cytogenetic Nomenclature","year":"2009"},{"key":"10.1016\/j.clml.2014.12.004_bib16","doi-asserted-by":"crossref","first-page":"625","DOI":"10.5858\/arpa.2012-0209-OA","article-title":"Plasma cell enrichment enhances detection of high-risk cytogenomic abnormalities by FISH and improves risk stratification of patients with plasma cell neoplasms","volume":"137","author":"Lu","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.clml.2014.12.004_bib17","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/jmg.39.3.214","article-title":"Familial pericentric inversion of chromosome 5 in a family with benign neonatal convulsions","volume":"39","author":"Concolino","year":"2002","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.clml.2014.12.004_bib18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000046636","article-title":"Cytogenetic and molecular genetic evolution of chronic myeloid leukemia","volume":"107","author":"Johansson","year":"2002","journal-title":"Acta Haematol"},{"key":"10.1016\/j.clml.2014.12.004_bib19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0165-4608(96)00278-6","article-title":"Variant Philadelphia translocation t(9;17)(q34.2-3;q21.3) with colocalization of the BCR and ABL genes on chromosome 9 in chronic myeloid leukemia","volume":"96","author":"Zhang","year":"1997","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.clml.2014.12.004_bib20","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3109\/10428199709039037","article-title":"Prognostic value of cytogenetic abnormalities in previously untreated patients with non-Hodgkin's lymphoma","volume":"25","author":"Juneja","year":"1997","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2014.12.004_bib21","first-page":"2698","article-title":"Chromosome abnormalities in malignant lymphoma in patients from Kurashiki: histological and immunophenotypic correlations","volume":"50","author":"Konishi","year":"1990","journal-title":"Cancer Res"},{"key":"10.1016\/j.clml.2014.12.004_bib22","doi-asserted-by":"crossref","first-page":"7041","DOI":"10.1038\/sj.onc.1209689","article-title":"Proteomics of acute myeloid leukaemia: cytogenetic risk groups differ specifically in their proteome, interactome and post-translational protein modifications","volume":"25","author":"Balkhi","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.clml.2014.12.004_bib23","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/hon.2025","article-title":"Structural alterations in chronic lymphocytic leukaemia. Cytogenetic and FISH analysis","volume":"31","author":"Travella","year":"2013","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.clml.2014.12.004_bib24","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1600-0609.2005.00616.x","article-title":"New chromosome abnormalities and lack of BCL-6 gene rearrangements in Argentinean diffuse large B-cell lymphomas","volume":"76","author":"Cerretini","year":"2006","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clml.2014.12.004_bib25","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1182\/blood.V86.4.1525.bloodjournal8641525","article-title":"TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignancies","volume":"86","author":"Sato","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.clml.2014.12.004_bib26","unstructured":"National Cancer Institute. Cancer Genome Anatomy Project. Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer. Available at: https:\/\/www.cgap.nci.nih.gov\/Chromosomes\/Mitelman. Accessed August 19,\u00a02014."},{"key":"10.1016\/j.clml.2014.12.004_bib27","first-page":"1134","article-title":"Silence of chromosomal amplifications in colon cancer","volume":"62","author":"Platzer","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.clml.2014.12.004_bib28","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1309\/CAUT52HJ535P9UG2","article-title":"Four-color flow cytometry identifies virtually all cytogenetically abnormal bone marrow samples in the workup of non-CML myeloproliferative disorders","volume":"120","author":"Kussick","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clml.2014.12.004_bib29","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.clml.2011.03.005","article-title":"Significance of thrombocytopenia in myelodysplastic syndromes: associations and prognostic implications","volume":"11","author":"Al Ameri","year":"2011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2014.12.004_bib30","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1182\/blood-2004-03-0982","article-title":"Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study Group","volume":"104","author":"Lenz","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.clml.2014.12.004_bib31","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1038\/sj.leu.2404850","article-title":"Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry study","volume":"21","author":"Montoto","year":"2007","journal-title":"Leukemia"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265014005394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265014005394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:26:24Z","timestamp":1761870384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265014005394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S2152265014005394"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2014.12.004","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Significance of Acquired Cytogenetic Clones in Patients With Treated Follicular Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2014.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}